Pharmabiz
 

Guj FDCA, US FDA & DIA to organise meet on changing global regulatory landscape from April 7-9

Suja Nair Shirodkar, MumbaiThursday, March 31, 2011, 08:00 Hrs  [IST]

The Gujarat Food & Drugs Control Administration (FDCA) in association with the US FDA and the Drug Information Association (DIA), Canada will be organising a three day regulatory conference on the changing global regulatory landscape. The event which will be held in Ahmedabad from April 7 to 9, aims at discussing the challenges within the domestic and global regulatory environment.

H G Koshia, commissioner of the Guj FDCA informed, “Through this event we intend to strengthen our relation with other regulatory bodies so that we can all work together to achieve a better regulatory environment. Our aim is to make the participants understand about the regulatory requirements for packaging and labeling along with explaining them and sensitising them about the challenges of medical device regulations.”

Koshia informs that the pharma manufacturers in the country are facing many challenges in the domestic and global regulatory environment which includes manufacturing and quality control, testing and packaging etc. “Through this conference we will have many interactive sessions with the regulatory officials from US, Canada, MHRA, India under the same roof. Our objective will be to clear doubts and give insight on the different strategies that can be adopted to achieve global regulatory compliance,” he added.

Koshia said that companies should attend this event since it is specifically designed to meet their demands. He said, “The event will focus on various regulatory affairs and public policies and will give insight on the best approach that can be adopted to ensure drug quality. There will be sharing of information on the current regulatory practices and presentation of many scientific papers that will be beneficial to the industry.”

It will also discuss on establishing standard operating procedures and trends of pharmaceutical manufacturing, testing and packaging and on the current status of the medical devices industry in the country. He informed that all attendees will receive a DIA Certificate of Attendance at the conclusion of the event.

 
[Close]